Because both CD146 and galectins are involved in the modulation of angiogenesis, researchers hypothesized that some galectins may be the ligands of CD146 and the interactions between them are required for functional CD146 in angiogenesis, as well as in cancer metastasis. This evidence concerns the gene MCAM and cancer.